Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Helperby Therapeutics Group

Helperby Therapeutics Group?uq=w9if130k
2004 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$618K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of antibiotic resistance breakers. The company's antibiotic resistance breakers offers a drug which rejuvenates old antibiotics, killing dormant and multidrug resistant bacteria, enabling patients to get a unique methodology which allows to rejuvenate old antibiotics, making them useful once again in treating infectious diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 26 Dover Street
  • London W1S 4LY
  • England

+44 020 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Helperby Therapeutics Group’s full profile, request a free trial.

Helperby Therapeutics Group Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 21-Oct-2015 $618K 000.00 00000 Completed Generating Revenue
3. Later Stage VC 24-Apr-2014 00.000 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 06-Jul-2012 $3.54M $8.01M 000.00 Completed Generating Revenue
1. Angel (individual) 01-Jan-2007 $4.47M $4.47M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Helperby Therapeutics Group Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 6 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 5 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 4 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 3 00,000 00.000000 000.00 000.00 00 000.00 0.00
Ordinary 2 82,150 $0.153205 $30.64 $30.64 1x $30.64 4.24%
Ordinary 1 143,771 $0.153205 $23.75 $23.75 1x $23.75 7.41%
To view this company’s complete Cap Table, request access »

Helperby Therapeutics Group Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Metellus Venture Capital Minority 000 0000 000000 0
Kenelm Storey Angel (individual) Minority 000 0000 000000 0

Helperby Therapeutics Group Executive Team (10)

Name Title Board
Seat
Contact
Info
Erik Kaathoven Chief Financial Officer
Frances Crewdson Chief Operating Officer & Senior Advisor
Anthony Coates MD Founder, Board Member & Chief Scientific Officer
Yanmin Hu Ph.D Director Of Research
Clive Page Senior Advisor
You’re viewing 5 of 10 executives. Get the full list »

Helperby Therapeutics Group Board Members (6)

Name Representing Role Since Contact
Info
Anthony Coates MD Helperby Therapeutics Group Founder, Board Member & Chief Scientific Officer 000 0000
Barry Clare Self Board Member 000 0000
Christopher Smith Helperby Therapeutics Group Senior Advisor & Board Member 000 0000
Kenelm Storey Self Chairman 000 0000
Till Medinger Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »